Sharps Technology (STSS) Competitors $3.57 +0.34 (+10.53%) (As of 02:35 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends STSS vs. STIM, FEMY, NXGL, NRXS, MDAI, MHUA, LFWD, IINN, PYPD, and NEPHShould you be buying Sharps Technology stock or one of its competitors? The main competitors of Sharps Technology include Neuronetics (STIM), Femasys (FEMY), NEXGEL (NXGL), NeurAxis (NRXS), Spectral AI (MDAI), Meihua International Medical Technologies (MHUA), ReWalk Robotics (LFWD), Inspira Technologies Oxy B.H.N. (IINN), PolyPid (PYPD), and Nephros (NEPH). These companies are all part of the "medical equipment" industry. Sharps Technology vs. Neuronetics Femasys NEXGEL NeurAxis Spectral AI Meihua International Medical Technologies ReWalk Robotics Inspira Technologies Oxy B.H.N. PolyPid Nephros Neuronetics (NASDAQ:STIM) and Sharps Technology (NASDAQ:STSS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation, earnings and community ranking. Which has better earnings & valuation, STIM or STSS? Sharps Technology has lower revenue, but higher earnings than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than Sharps Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuronetics$71.35M0.35-$30.19M-$1.23-0.67Sharps TechnologyN/AN/A-$9.84M-$8.08-0.44 Is STIM or STSS more profitable? Sharps Technology has a net margin of 0.00% compared to Neuronetics' net margin of -50.09%. Sharps Technology's return on equity of -110.40% beat Neuronetics' return on equity.Company Net Margins Return on Equity Return on Assets Neuronetics-50.09% -141.24% -32.77% Sharps Technology N/A -110.40%-73.60% Do institutionals & insiders hold more shares of STIM or STSS? 53.6% of Neuronetics shares are owned by institutional investors. Comparatively, 17.2% of Sharps Technology shares are owned by institutional investors. 9.8% of Neuronetics shares are owned by company insiders. Comparatively, 8.7% of Sharps Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community believe in STIM or STSS? Neuronetics received 127 more outperform votes than Sharps Technology when rated by MarketBeat users. However, 100.00% of users gave Sharps Technology an outperform vote while only 68.45% of users gave Neuronetics an outperform vote. CompanyUnderperformOutperformNeuroneticsOutperform Votes12868.45% Underperform Votes5931.55% Sharps TechnologyOutperform Votes1100.00% Underperform VotesNo Votes Which has more risk & volatility, STIM or STSS? Neuronetics has a beta of 2.21, suggesting that its share price is 121% more volatile than the S&P 500. Comparatively, Sharps Technology has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Does the media prefer STIM or STSS? In the previous week, Neuronetics had 7 more articles in the media than Sharps Technology. MarketBeat recorded 9 mentions for Neuronetics and 2 mentions for Sharps Technology. Sharps Technology's average media sentiment score of 0.66 beat Neuronetics' score of -0.10 indicating that Sharps Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neuronetics 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Sharps Technology 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate STIM or STSS? Neuronetics presently has a consensus target price of $4.67, suggesting a potential upside of 462.25%. Given Neuronetics' stronger consensus rating and higher probable upside, equities research analysts plainly believe Neuronetics is more favorable than Sharps Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neuronetics 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Sharps Technology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryNeuronetics beats Sharps Technology on 11 of the 17 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Sharps Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for STSS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STSS vs. The Competition Export to ExcelMetricSharps TechnologySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.94M$4.43B$5.08B$8.80BDividend YieldN/A36.79%5.02%4.07%P/E Ratio-0.4113.5791.2813.60Price / SalesN/A44.221,226.2187.40Price / CashN/A52.2739.4536.27Price / Book0.915.776.906.33Net Income-$9.84M$13.76M$118.83M$225.93M7 Day Performance17.44%-0.99%-1.92%-0.96%1 Month Performance7.49%0.71%-3.75%1.06%1 Year PerformanceN/A51.46%31.37%26.59% Sharps Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STSSSharps Technology0.7782 of 5 stars$3.57+10.5%N/AN/A$6.43MN/A-0.443Gap DownSTIMNeuronetics2.4609 of 5 stars$0.83+3.4%$4.67+462.2%-40.6%$25.19M$71.35M0.00180FEMYFemasys2.4841 of 5 stars$1.01+3.4%$10.00+890.1%+2.8%$23.13M$1.07M0.0030Analyst RevisionNXGLNEXGEL1.444 of 5 stars$3.30flatN/A+84.4%$22.41M$4.09M0.0010NRXSNeurAxisN/A$3.15-1.3%N/A+35.9%$21.99M$2.46M0.0019MDAISpectral AI2.5746 of 5 stars$1.05-1.4%$4.50+330.6%-59.4%$19.43M$18.06M0.0078MHUAMeihua International Medical Technologies0.3433 of 5 stars$0.69+6.9%N/A-66.4%$17.41M$97.10M0.00620Gap UpLFWDReWalk Robotics3.5648 of 5 stars$1.94+4.9%$13.00+570.1%N/A$17.09M$13.85M-0.7460IINNInspira Technologies Oxy B.H.N.0.3151 of 5 stars$1.34+1.5%N/A+11.3%$16.91MN/A0.0020News CoverageGap UpPYPDPolyPid2.877 of 5 stars$3.43-1.7%$12.00+249.9%-14.3%$16.46MN/A0.0080Positive NewsGap DownNEPHNephros2.2003 of 5 stars$1.56-1.9%$5.00+220.5%-24.3%$16.44M$14.24M0.0030Gap Down Related Companies and Tools Related Companies Neuronetics Competitors Femasys Competitors NEXGEL Competitors NeurAxis Competitors Spectral AI Competitors Meihua International Medical Technologies Competitors ReWalk Robotics Competitors Inspira Technologies Oxy B.H.N. Competitors PolyPid Competitors Nephros Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:STSS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sharps Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sharps Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STSS Stock Alerts